PULSE BIOSCIENCES INC (PLSE) Stock Price, Quote, News and Overview
NASDAQ:PLSE - Nasdaq - US74587B1017 - Common Stock - Currency: USD
PLSE Quote, Performance and Key Statistics
NASDAQ:PLSE (4/22/2025, 9:57:04 AM)
17.75
+0.46 (+2.66%)
The current stock price of PLSE is 17.75 USD. In the past month the price increased by 7.66%. In the past year, price increased by 140.47%.
PLSE Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 27.41 | 227.20B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.14 | 168.44B | ||
| BSX | BOSTON SCIENTIFIC CORP | 37.59 | 139.55B | ||
| SYK | STRYKER CORP | 28.1 | 130.72B | ||
| MDT | MEDTRONIC PLC | 15.51 | 106.21B | ||
| BDX | BECTON DICKINSON AND CO | 14.29 | 57.09B | ||
| EW | EDWARDS LIFESCIENCES CORP | 26.57 | 40.93B | ||
| IDXX | IDEXX LABORATORIES INC | 36.81 | 33.56B | ||
| RMD | RESMED INC | 24.18 | 31.39B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.69 | 28.14B | ||
| DXCM | DEXCOM INC | 40.34 | 26.10B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 15.25 | 22.50B |
Related stock screener links
About PLSE
Company Profile
Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. The company is headquartered in Hayward, California and currently employs 56 full-time employees. The company went IPO on 2016-05-18. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The firm is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The firm has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Company Info
PULSE BIOSCIENCES INC
3957 Point Eden Way
Hayward CALIFORNIA 94545 US
CEO: Darrin R. Uecker
Employees: 56
Company Website: https://www.pulsebiosciences.com/
Investor Relations: https://investors.pulsebiosciences.com/
Phone: 15109064600
PULSE BIOSCIENCES INC / PLSE FAQ
What is the stock price of PULSE BIOSCIENCES INC today?
The current stock price of PLSE is 17.75 USD. The price increased by 2.66% in the last trading session.
What is the ticker symbol for PULSE BIOSCIENCES INC stock?
The exchange symbol of PULSE BIOSCIENCES INC is PLSE and it is listed on the Nasdaq exchange.
On which exchange is PLSE stock listed?
PLSE stock is listed on the Nasdaq exchange.
What is PULSE BIOSCIENCES INC worth?
PULSE BIOSCIENCES INC (PLSE) has a market capitalization of 1.19B USD. This makes PLSE a Small Cap stock.
How many employees does PULSE BIOSCIENCES INC have?
PULSE BIOSCIENCES INC (PLSE) currently has 56 employees.
What are the support and resistance levels for PULSE BIOSCIENCES INC (PLSE) stock?
PULSE BIOSCIENCES INC (PLSE) has a support level at 15.55 and a resistance level at 17.41. Check the full technical report for a detailed analysis of PLSE support and resistance levels.
Should I buy PULSE BIOSCIENCES INC (PLSE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PLSE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PLSE, evaluating the profitability, health, valuation and growth aspects
- PULSE BIOSCIENCES INC (PLSE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PULSE BIOSCIENCES INC (PLSE) Sales and EPS estimates to see what analysts future expectations are.
- PULSE BIOSCIENCES INC (PLSE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PULSE BIOSCIENCES INC (PLSE) Insider and Institutional Ownership to learn about the owners and their transactions.
- PULSE BIOSCIENCES INC (PLSE) Stock Chart to make your own analysis
- PULSE BIOSCIENCES INC (PLSE) Latest news and press-releases to stay up to date.
Does PULSE BIOSCIENCES INC (PLSE) stock pay dividends?
PLSE does not pay a dividend.
When does PULSE BIOSCIENCES INC (PLSE) report earnings?
PULSE BIOSCIENCES INC (PLSE) will report earnings on 2025-05-07.
What is the Price/Earnings (PE) ratio of PULSE BIOSCIENCES INC (PLSE)?
PULSE BIOSCIENCES INC (PLSE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.78).
What is the Short Interest ratio of PULSE BIOSCIENCES INC (PLSE) stock?
The outstanding short interest for PULSE BIOSCIENCES INC (PLSE) is 19.22% of its float. Check the ownership tab for more information on the PLSE short interest.
PLSE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to PLSE. When comparing the yearly performance of all stocks, PLSE is one of the better performing stocks in the market, outperforming 97.93% of all stocks.
PLSE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PLSE. While PLSE has a great health rating, there are worries on its profitability.
PLSE Financial Highlights
Over the last trailing twelve months PLSE reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS increased by 55.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -40.45% | ||
| ROE | -46.65% | ||
| Debt/Equity | 0 |
PLSE Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to PLSE. The Buy consensus is the average rating of analysts ratings from 6 analysts.